Sensyne delivers strong revenue growth but warns of short term slowdown

Sensyne Health CEO Paul Drayson
Paul Drayson, CEO, Sensyne Health

Clinical AI company Sensyne Health has booked a £7m jump in revenue to £9.1m as new and existing agreements with life science companies delivered strong growth. The company, which raised £27.5m from a placing in January, entered into a number of collaboration agreements in the year to 30 April, including a strategic collaboration with US…

You must be a HM Subscriber to view this content.

Subscribe Now »